Related Experiment Videos
Structure-based design of peptidomimetic antagonists of p56(lck) SH2 domain
Christopher J Hobbs1, Rino A Bit, Andrew D Cansfield
1Roche Products Limited, 40 Broadwater Road, Welwyn Garden City, AL7 3AY, Hertfordshire, UK. chobbs@ionixpharma.com
Bioorganic & Medicinal Chemistry Letters
|May 7, 2002
Abstract:
Starting from the tetrapeptide Ac-pYEEI-NHMe and using a structure-based approach, we have designed and synthesised a peptidomimetic ligand for p56(lck) SH2 domain containing a conformationally restricted replacement for the two glutamate residues. We have explored replacments for the isoleucine residue in the pY+3 pocket and thus identified 1-(R)-amino-3-(S)-indaneacetic acid as the most potent replacement. We also report the X-ray crystal structures of two of the antagonists.